This inventor holds 2 USPTO granted patents. Top assignees: Aventis Behring Gmbh, Csl Behring Gmbh. Active years: 2007-2011.
Company Filing History:
Years Active: 2007-2011
Title: Anne Bellon: Innovator in Prion Detection
Introduction
Anne Bellon is a distinguished inventor based in Marburg, Germany. She has made significant contributions to the field of biomedical research, particularly in the detection of pathogenic prions. With a total of 2 patents to her name, her work is pivotal in advancing diagnostic methods for prion diseases.
Latest Patents
Her latest patents focus on antibodies specifically designed for detecting pathogenic prions of human origin. These antibodies are characterized by their ability to bind to an epitope unique to human prion proteins, which are not found in prion proteins from other species. The patents also describe a conformation-dependent immunoassay method for detecting pathogenic prions in samples containing prion (PrP) proteins. This method distinguishes between different conformations of the PrP protein, which exhibit varying binding affinities for the antibodies used in detection.
Career Highlights
Anne has worked with notable companies in the biotechnology sector, including Aventis Behring GmbH and CSL Behring GmbH. Her experience in these organizations has contributed to her expertise in prion research and antibody development.
Collaborations
Throughout her career, Anne has collaborated with esteemed colleagues such as Martin Vey and Albrecht Groener. These partnerships have further enriched her research and innovation in the field.
Conclusion
Anne Bellon's work in the detection of pathogenic prions represents a significant advancement in biomedical research. Her innovative approaches and collaborations continue to pave the way for improved diagnostic methods in prion diseases.